Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam D Durbin

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
EJC Paediatric Oncology|August 20, 2025
Cell state plasticity in neuroblastomaAdam D Durbin, Rogier Versteeg
Cold Spring Harbor Perspectives in Medicine|May 28, 2024
Lineage-Selective Dependencies in Pediatric CancersK Elaine Ritter, Adam D Durbin
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 6, 2002
Advances towards understanding heart valve response to injuryAdam D Durbin, Avrum I Gotlieb
Clinical & Experimental Metastasis|September 5, 2007
The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stromaBrigitte Strahm, Adam D Durbin, Elizabeth Sexsmith, et al.
Molecular & Cellular Oncology|February 8, 2021
Targeting ganglioneuromas with mTOR inhibitorsTing Tao, Hui Shi, Adam D Durbin, et al.
Advances in Experimental Medicine and Biology|May 12, 2016
Malignant Peripheral Nerve Sheath TumorsAdam D Durbin, Dong Hyuk Ki, Shuning He, et al.
Oncogene|August 25, 2019
Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumorsDong Hyuk Ki, Felix Oppel, Adam D Durbin, et al.
Frontiers in Cell and Developmental Biology|February 4, 2025
Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcomaAnnika L Gustafson, Adam D Durbin, Kristin B Artinger, et al.
Cancer Research|May 3, 2008
The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifenJoshua A Greenberg, Stig Somme, Hege E Russnes, et al.
Cell Reports. Medicine|May 18, 2022
Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insightsNoha A M Shendy, Mark W Zimmerman, Brian J Abraham, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
EJC Paediatric Oncology|August 20, 2025
Cell state plasticity in neuroblastomaAdam D Durbin, Rogier Versteeg
Cold Spring Harbor Perspectives in Medicine|May 28, 2024
Lineage-Selective Dependencies in Pediatric CancersK Elaine Ritter, Adam D Durbin
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 6, 2002
Advances towards understanding heart valve response to injuryAdam D Durbin, Avrum I Gotlieb
Clinical & Experimental Metastasis|September 5, 2007
The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stromaBrigitte Strahm, Adam D Durbin, Elizabeth Sexsmith, et al.
Molecular & Cellular Oncology|February 8, 2021
Targeting ganglioneuromas with mTOR inhibitorsTing Tao, Hui Shi, Adam D Durbin, et al.
Advances in Experimental Medicine and Biology|May 12, 2016
Malignant Peripheral Nerve Sheath TumorsAdam D Durbin, Dong Hyuk Ki, Shuning He, et al.
Oncogene|August 25, 2019
Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumorsDong Hyuk Ki, Felix Oppel, Adam D Durbin, et al.
Frontiers in Cell and Developmental Biology|February 4, 2025
Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcomaAnnika L Gustafson, Adam D Durbin, Kristin B Artinger, et al.
Cancer Research|May 3, 2008
The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifenJoshua A Greenberg, Stig Somme, Hege E Russnes, et al.
Cell Reports. Medicine|May 18, 2022
Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insightsNoha A M Shendy, Mark W Zimmerman, Brian J Abraham, et al.
Pageof 6